BIOMAT Database Logo BIOMAT Database Logo

New Derivatives of 5-((1-Methyl-Pyrrol-2-yl) Methyl)-4-(Naphthalen-1-yl)-1,2,4-Triazoline-3-Thione and Its Coordination Compounds with Anticancer Activity. 2022

Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland.

A new ligand 5-((1-methyl-pyrrol-2-yl) methyl)-4-(naphthalen-1-yl)-1,2,4-triazoline-3-thione (C15) and its metal complexes with formulae: Mn(C15)Cl2MeOH (1), Fe(C15)Cl2MeOH (2), Ni(C15)Cl2MeOH (3), Cu(C15)2Cl2 (4) and Zn(C15)4Cl2 (5) have been synthesized. The C15 ligand and complexes were characterized by NMR, elemental analysis, FT-IR, EPR, magnetic and TGA studies. The anticancer activities of the organic ligand (C15) and complexes (1-5) were evaluated against human colon adenocarcinoma (HT29) and human lung (A549) cancer cell lines. The complex (1) exhibited potential activity at concentration of 794.37 μM (A549) and 654.31 μM (HT29) in both cancer cells. The complex (3) showed significant activity against the HT29 cancer cell line with an IC50 value of 1064.05 μM. This article highlights some of the metals that have become important in the development of new coordination complexes and the treatment of cancer. Additionally, for C15, the toxicity was predicted by ADMET analysis and molecular docking.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013871 Thiones Sulfur-containing compounds also known as thioketones of general formula R2C Thioketone,Thione,Thioketones
D017550 Spectroscopy, Fourier Transform Infrared A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained. FTIR,Fourier Transform Infrared Spectroscopy,Spectroscopy, Infrared, Fourier Transform
D056831 Coordination Complexes Neutral or negatively charged ligands bonded to metal cations or neutral atoms. The number of ligand atoms to which the metal center is directly bonded is the metal cation's coordination number, and this number is always greater than the regular valence or oxidation number of the metal. A coordination complex can be negative, neutral, or positively charged. Metal Complexes,Complexes, Coordination,Complexes, Metal
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
Synthesis of new derivatives of 1-(2-aminoethyl)-4-phenyl-3-(pyridin-3-yl)-1,2,4-triazoline-5-thione.
December 2004, Acta poloniae pharmaceutica,
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
4-Ethyl-3-(2-thienylmeth-yl)-Δ-1,2,4-triazoline-5-thione.
January 2009, Acta crystallographica. Section E, Structure reports online,
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
Synthesis of 1-substituted-4-ethyl-3-(pyridin-3-yl)-1,2,4-triazoline-5-thione.
December 2004, Acta poloniae pharmaceutica,
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
Synthesis and anticonvulsant activity of some new 1,1-bis(4-substituted 1,2,4-triazoline-5-thione-3-yl)-2-methylbutanes.
March 1995, Farmaco (Societa chimica italiana : 1989),
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
Synthesis of 1-aminomethyl derivatives of 3-benzyl-4-ethyl- 1,2,4-triazoline-5-thione.
January 2006, Acta poloniae pharmaceutica,
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
Synthesis and biological activity of new derivatives of 3-phenoxymethyl-4-R-D2-1,2,4-triazoline-5-thione.
December 2004, Acta poloniae pharmaceutica,
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
Synthesis and some pharmacological properties of 3-(piperidin-4-yl)-4-substituted-D2-1,2,4-triazoline-5-thione derivatives.
December 2004, Acta poloniae pharmaceutica,
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
R(+)-1,2-Bis(4-substituted-1,2,4-triazoline-5-thione-3-yl)glycol and related compounds as potential pesticides.
November 1978, Archiv der Pharmazie,
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
4-Amino-3-{1-[4-(2-methyl-prop-yl)phen-yl]eth-yl}-1H-1,2,4-triazole-5(4H)-thione.
July 2008, Acta crystallographica. Section E, Structure reports online,
Agnieszka Czylkowska, and Suneel Lanka, and Małgorzata Szczesio, and Kamila Czarnecka, and Paweł Szymański, and Monika Pitucha, and Aneta Drabińska, and Bruno Cury Camargo, and Jacek Szczytko
3-{1-[4-(2-Methyl-prop-yl)phen-yl]eth-yl}-4-phenyl-1H-1,2,4-triazole-5(4H)-thione.
August 2011, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!